Hitoshi Kashiwagi

681 total citations
48 papers, 493 citations indexed

About

Hitoshi Kashiwagi is a scholar working on Pharmacology, Infectious Diseases and Surgery. According to data from OpenAlex, Hitoshi Kashiwagi has authored 48 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 9 papers in Infectious Diseases and 7 papers in Surgery. Recurrent topics in Hitoshi Kashiwagi's work include Inflammatory mediators and NSAID effects (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Hitoshi Kashiwagi is often cited by papers focused on Inflammatory mediators and NSAID effects (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Hitoshi Kashiwagi collaborates with scholars based in Japan, United States and Bangladesh. Hitoshi Kashiwagi's co-authors include Fumitaka Ushikubi, Yoh Takekuma, Mitsuru Sugawara, Shungo Imai, Koh-ichi Yuhki, Shuh Narumiya, Takayuki Miyai, Takayuki Fujino, Yuki Sato and Kenji Momo and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Hitoshi Kashiwagi

44 papers receiving 491 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hitoshi Kashiwagi Japan 12 150 110 85 85 53 48 493
Ruolan Dong China 17 61 0.4× 276 2.5× 50 0.6× 94 1.1× 77 1.5× 30 697
Jihui Chen China 14 71 0.5× 217 2.0× 37 0.4× 37 0.4× 51 1.0× 35 536
Yaomin Du China 8 64 0.4× 133 1.2× 141 1.7× 58 0.7× 22 0.4× 8 421
Richard Fux Germany 10 84 0.6× 196 1.8× 50 0.6× 26 0.3× 20 0.4× 16 540
Elsa Pennese Italy 6 68 0.5× 95 0.9× 143 1.7× 95 1.1× 71 1.3× 9 738
P Perna Italy 6 88 0.6× 71 0.6× 95 1.1× 159 1.9× 31 0.6× 12 668
Amarjit S. Chaudhry United States 17 78 0.5× 182 1.7× 25 0.3× 41 0.5× 12 0.2× 20 737
Douglas T. Thudium United States 5 64 0.4× 279 2.5× 104 1.2× 27 0.3× 65 1.2× 5 858
Jian‐Quan Luo China 17 51 0.3× 213 1.9× 87 1.0× 15 0.2× 55 1.0× 42 709
Suparat Khamdang Japan 10 131 0.9× 283 2.6× 31 0.4× 120 1.4× 18 0.3× 12 1.4k

Countries citing papers authored by Hitoshi Kashiwagi

Since Specialization
Citations

This map shows the geographic impact of Hitoshi Kashiwagi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hitoshi Kashiwagi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hitoshi Kashiwagi more than expected).

Fields of papers citing papers by Hitoshi Kashiwagi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hitoshi Kashiwagi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hitoshi Kashiwagi. The network helps show where Hitoshi Kashiwagi may publish in the future.

Co-authorship network of co-authors of Hitoshi Kashiwagi

This figure shows the co-authorship network connecting the top 25 collaborators of Hitoshi Kashiwagi. A scholar is included among the top collaborators of Hitoshi Kashiwagi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hitoshi Kashiwagi. Hitoshi Kashiwagi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Inoue, Yuki, et al.. (2024). Exploring the impact of baseline platelet count on linezolid-induced thrombocytopenia: a retrospective single-center observation study. International Journal of Clinical Pharmacy. 47(1). 90–98.
2.
Mori, Ayako, Izumi Kato, Katsuya Narumi, et al.. (2023). Quantitative analysis of communication changes in online medication counseling using the Roter Interaction System. Research in Social and Administrative Pharmacy. 20(1). 36–42. 1 indexed citations
3.
Inoue, Yuki, et al.. (2023). Monitoring Salivary Concentrations of Tedizolid and Linezolid Using Rats. European Journal of Drug Metabolism and Pharmacokinetics. 48(4). 387–395. 2 indexed citations
4.
Inoue, Yuki, Yoh Takekuma, Takayuki Miyai, et al.. (2023). Use of Japanese big data from electronic medical records to investigate risk factors and identify their high-risk combinations for linezolid-induced thrombocytopenia. European Journal of Clinical Pharmacology. 79(3). 415–425. 9 indexed citations
5.
Imai, Shungo, Takayuki Miyai, Hitoshi Kashiwagi, et al.. (2022). Using Japanese big data to investigate novel factors and their high‐risk combinations that affect vancomycin‐induced nephrotoxicity. British Journal of Clinical Pharmacology. 88(7). 3241–3255. 19 indexed citations
6.
Miyamoto, Yasushi, et al.. (2022). Hepatic drug metabolism in older people with body composition changes. Geriatrics and gerontology international. 22(5). 449–454. 3 indexed citations
7.
Sato, Yuki, et al.. (2022). Development of a Method of Liquid Chromatography Coupled with Tandem Mass Spectrometry for Simultaneous Determination of Linezolid and Tedizolid in Human Plasma. Biological and Pharmaceutical Bulletin. 45(4). 421–428. 4 indexed citations
8.
Imai, Shungo, Kenji Momo, Hitoshi Kashiwagi, et al.. (2021). A cross-sectional survey of hospitalization and blood tests implementation status in patients who received tolvaptan under 75 years of age using a Japanese claims database. Expert Opinion on Drug Safety. 20(10). 1257–1266. 1 indexed citations
9.
Imai, Shungo, Hitoshi Kashiwagi, Yuki Sato, et al.. (2021). Factors affecting creatine phosphokinase elevation during daptomycin therapy using a combination of machine learning and conventional methods. British Journal of Clinical Pharmacology. 88(3). 1211–1222. 11 indexed citations
10.
Aoyama, Tsuyoshi, Hiroki Kuriyama, Yuki Sato, et al.. (2021). cAMP Signaling Pathway Prevents Dasatinib-Induced Vascular Hyperpermeability. Biological and Pharmaceutical Bulletin. 44(8). 1101–1110. 2 indexed citations
11.
Yamashita, Shinsuke, Shungo Imai, Kenji Momo, et al.. (2021). Investigation of the Real-World Situation and Risk Factors Associated with Olanzapine Prescribed to Diabetes Patients by Using a Japanese Claims Database. Biological and Pharmaceutical Bulletin. 44(8). 1151–1155. 1 indexed citations
12.
Imai, Shungo, Yoh Takekuma, Hitoshi Kashiwagi, et al.. (2020). Validation of the usefulness of artificial neural networks for risk prediction of adverse drug reactions used for individual patients in clinical practice. PLoS ONE. 15(7). e0236789–e0236789. 31 indexed citations
13.
Miyai, Takayuki, Shungo Imai, Hitoshi Kashiwagi, et al.. (2020). A Risk Prediction Flowchart of Vancomycin-Induced Acute Kidney Injury to Use When Starting Vancomycin Administration: A Multicenter Retrospective Study. Antibiotics. 9(12). 920–920. 17 indexed citations
14.
Imai, Shungo, Kenji Momo, Hitoshi Kashiwagi, et al.. (2020). Comparison of interactions between warfarin and cephalosporins with and without the N-methyl-thio-tetrazole side chain. Journal of Infection and Chemotherapy. 26(11). 1224–1228. 6 indexed citations
15.
Imai, Shungo, Kenji Momo, Hitoshi Kashiwagi, et al.. (2020). Nonsteroidal anti‐inflammatory drugs use in patients with chronic kidney disease are often prescribed from different clinicians than those who diagnosed them. Pharmacoepidemiology and Drug Safety. 29(8). 873–880. 5 indexed citations
16.
Imai, Shungo, Kenji Momo, Hitoshi Kashiwagi, et al.. (2020). Association of the ward pharmacy service with active implementation of therapeutic drug monitoring for vancomycin and teicoplanin—an epidemiological surveillance study using Japanese large health insurance claims database. Journal of Pharmaceutical Health Care and Sciences. 6(1). 18–18. 11 indexed citations
17.
Nakagawa, Naoki, Koh-ichi Yuhki, Takayuki Fujino, et al.. (2012). The intrinsic prostaglandin E2–EP4 system of the renal tubular epithelium limits the development of tubulointerstitial fibrosis in mice. Kidney International. 82(2). 158–171. 67 indexed citations
18.
Kojima, Fumiaki, Koh‐ichi Yuhki, Hitoshi Kashiwagi, & Fumitaka Ushikubi. (2010). [Prostaglandin E1, E2 and their metabolites].. PubMed. 68 Suppl 7. 20–4. 1 indexed citations
19.
Kono, Ichiro, et al.. (1985). Beneficial effect of topical fibronectin in patients with keratoconjunctivitis sicca of Sjögren's syndrome.. PubMed. 12(3). 487–9. 19 indexed citations
20.
Kashiwagi, Hitoshi, et al.. (1978). Septicemia due to Aeromonas hydrophila in patients with acute leukemia: clinical and bacteriologial features and a possible beneficial effect on hematological remission.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 41(4). 719–26. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ruolan Dong Breakdown of academic impact, for papers by Jihui Chen Breakdown of academic impact, for papers by Yaomin Du Breakdown of academic impact, for papers by Richard Fux Breakdown of academic impact, for papers by Elsa Pennese Breakdown of academic impact, for papers by P Perna Breakdown of academic impact, for papers by Amarjit S. Chaudhry Breakdown of academic impact, for papers by Douglas T. Thudium Breakdown of academic impact, for papers by Jian‐Quan Luo Breakdown of academic impact, for papers by Suparat Khamdang
Rankless by CCL
2026